⌕
DENTSPLY Sirona · XRAY · Nasdaq
Tenet 38 · Weak
Compare
$8.95−2.35%At closeTenet 38 · Weak
$8.95−0.22 (−2.35%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

DENTSPLY Sirona (XRAY) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 3.0% in FY25, net margin −16.2%. Worth your attention in FY25: Returns vs FCF (123%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼3.0%
3,680.0
FY21→FY25CAGR −3.4%/yr
Net income ($M)▲34.3%
−598.0
one-off year: see footnoteCAGR —
Free cash flow ($M)▼63.0%
104.0
FY21→FY25CAGR −33.0%/yr
Diluted EPS▲33.0%
−3.00
buyback-liftedCAGR —
What the receipts whisper · what a headline number hides
Share count
−9.4%

220.2mn → 199.4mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$131.0M

−27.2% YoY in FY25 · 3.6% of revenue.

Returns vs FCF
123%

$128.0M returned vs $104.0M of FCF in FY25. The gap comes off the balance sheet (see net cash).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)3680.0Revenue−1840.0COGS1840.0Gross profit−150.0R&D−1438.0SG&A−422.0Op income−176.0Tax & other−598.0Net income

-16¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
604530150%sector median net margin ~4%FY21FY25

Over this window: gross 55.5% → 50.0%. Net margin -16.3% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
3,575.03,680.03,793.03,965.03,922.04,231.0▼3.0%−3.4%
Cost of revenue
1,769.01,840.01,835.01,879.01,795.01,884.0▲0.3%−0.6%
Gross profit
1,806.01,840.01,958.02,086.02,127.02,347.0▼6.0%−5.9%
Research & development
171.0150.0165.0184.0174.0171.0▼9.1%−3.2%
Selling, general & admin
1,461.01,438.01,605.01,613.01,589.01,551.0▼10.4%−1.9%
Total operating expenses
1,861.02,262.02,837.02,171.03,064.01,739.0▼20.3%+6.8%
Operating incomefeeds ROC rank
−55.0−422.0−879.0−85.0−937.0608.0▲52.0%—
Other income, net
−36.0−64.0−57.0−90.0−118.0−63.0——
Pretax income
−91.0−486.0−936.0−175.0−1,055.0545.0▲48.1%—
Income tax
31.0112.0−26.0−43.0−105.0134.0—−4.4%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−122.0−598.0−910.0−132.0−950.0411.0▲34.3%—
Per share
Diluted EPSbuyback-sensitive
−0.62−3.00−4.48−0.62−4.411.87▲33.0%—
Diluted shares (mn)
199.20199.40203.20212.00215.50220.20▼1.9%−2.5%
Margins
Gross margin28th pct in Healthcare
50.5%50.0%51.6%52.6%54.2%55.5%▼1.6pp−5.5pp
Operating margin
−1.5%−11.5%−23.2%−2.1%−23.9%14.4%▲11.7pp−25.8pp
Net margin34th pct in Healthcare
−3.4%−16.3%−24.0%−3.3%−24.2%9.7%▲7.7pp−26.0pp
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 25% vs a 10% norm for this window, likely a one-time item; see the filing.FY23 effective tax rate was 25% vs a 10% norm for this window, likely a one-time item; see the filing.
FY08 – FY20 · 13 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 13 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was DENTSPLY Sirona's revenue last fiscal year?

DENTSPLY Sirona reported revenue of $3,680.0M in fiscal 2025, down 3.0% from fiscal 2024.

What was DENTSPLY Sirona's net income?

DENTSPLY Sirona reported net income of −$598.0M in fiscal 2025, a net margin of −16.3%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.